Single center experience with Advanta V12 covered stent in the endovascular treatment of occlusive aorto-iliac disease Dr L. Briner, Dr F. Marra, Dr. C. Dubuis, Dr F. Saucy , Prof J-M. Corpataux , Dr S. Déglise Dpt of Vascular Surgery, CHUV Lausanne, Background • Open surgery: excellent and durable results for aorto-iliac occlusive disease • Endovascular: high technical success and low complications rates è Role of covered stents to increase mid and long-term patency? • Material and Methods • Retrospective analysis of prospective data retrieved from 1 center January 2013 - September 2015 • All consecutive patients with aorto-iliac occlusive disease • Endpoints: o patency rates o postoperative morbidity o re-interventions Results • 31 patients: o Mean age 64.5 years (range 50-86) o H:F : 5:26 • Technical success: 100% • No death • Characteristics of stents: • N=52 • Mean diameter 9.3 mm • Mean length: 49.9 mm Conclusion: The endovascular treatment of aorto-iliac occlusive disease using Advanta V12 stents is a safe and useful strategy. It seems to offer satisfactory results in term of immediate success and mid-term patency rates. It could be a valid alternative to open surgery but larger trials and registries are needed to draw definitive conclusions.. N (%) Indications Claudication Critical ischemia Acute ischemia 31 25 (81) 5 (16) 1 (3) TASC II classification A B C D 31 2 (6) 18 (58) 6 (18) 5 (16) N (%) Operative time (min) 110 (25-200) Contrast volume (ml) 92 (30-150) Reconstruction CERAB Bilat CIA Unilat CIA 31 5 (16) 10 (32) 16 (52) Percutaneous 14 (45) N (%) Post -op complications False aneurysm Wound infection Distal embolization 3 (9) 1 (3) 1 (3) 1 (3) F-U complications In-stent restenosis In-stent occlusion 3 (9) 2 (6) 1 (3) Re-intervention Thombectomy Angioplasty 4 (12) 2 (6) 2 (6) Covered Endovascular R econstruction Aortic Bifurcation
Welcome message from author
This document is posted to help you gain knowledge. Please leave a comment to let me know what you think about it! Share it to your friends and learn new things together.
Transcript
SinglecenterexperiencewithAdvanta V12coveredstentintheendovasculartreatmentofocclusive
aorto-iliacdiseaseDr L. Briner, Dr F. Marra, Dr. C. Dubuis, Dr F. Saucy , Prof J-M. Corpataux , Dr S. Déglise
Dpt of Vascular Surgery, CHUV Lausanne,
Background• Open surgery: excellent and durable results for aorto-iliac occlusive disease• Endovascular: high technical success and low complications rates
è Role of covered stents to increase mid and long-term patency?
• Material and Methods• Retrospective analysis of prospective data retrieved from 1
center January 2013 - September 2015 • All consecutive patients with aorto-iliac occlusive disease• Endpoints:
o patency rateso postoperative morbidity o re-interventions
Results• 31 patients:
o Mean age 64.5 years (range 50-86)o H:F : 5:26
• Technical success: 100%• No death• Characteristics of stents:
• N = 52• Mean diameter 9.3 mm• Mean length: 49.9 mm
Conclusion:The endovascular treatment of aorto-iliac occlusive disease using Advanta V12 stents is a safe and useful strategy. It seems to offer satisfactory results in term of immediate success and mid-term patency rates. It could be a valid alternative to open surgery but larger trials and registries are needed to draw definitive conclusions..
N(%)Indications
ClaudicationCriticalischemiaAcuteischemia
3125(81)5(16)1 (3)
TASCIIclassificationABCD
312(6)18(58)6(18)5(16)
N(%)Operative time(min) 110 (25-200)
Contrastvolume(ml) 92(30-150)
ReconstructionCERABBilat CIAUnilat CIA
315(16)10(32)16(52)
Percutaneous 14(45)
N(%)Post-op complications
FalseaneurysmWound infectionDistalembolization
3(9)1(3)1(3)1(3)
F-UcomplicationsIn-stentrestenosisIn-stentocclusion
3(9)2(6)1(3)
Re-interventionThombectomyAngioplasty
4 (12)2(6)2(6)
CoveredEndovascularReconstructionAorticBifurcation
Related Documents
